In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 67 for your search:
Drug:  tipifarnib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00535, E2902, U10CA021115, CDR0000387995, ECOG-E2902, NCT00093470
2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 70 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004372, NCT00093990
3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR003976, R115777-INT-11, JRF-R115777-INT-11, NCT00005648
4.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067864, SUMC-NCI-38, NCI-38, 38, NCT00005846
5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01442, MC0131, N01CM62205, CDR0000331694, MAYO-MC0131, NCI-5599, 5599, WSU-C-2679, NCT00070252
6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ID02-126, NCT00050986
7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 to 70
Sponsor: NCI
Protocol IDs: NCI-2012-02862, 2003-0563, N01CM62202, MDA-2003-0563, NCI-6625, 6625, NCT00096122
8.

Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00114, 2003-0992, N01CM17003, N01CM62202, MDA-2003-0992, 7004, NCI-7004, NCT00100750
9.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02675, VEL-04-111, R01CA083978, CDR0000446083, MCC-VEL-04-111, 7032, NCI-7032, NCT00243035
10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00676, NABTC-05-02, CDR0000476286, U01CA137443, ABTC-05-02, NCT00335764
11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00239, 06-12-487, CDR0000543434, N01CM62202, N01CM62204, NYCC-06-12-487, 7868, NCT00470301
12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 3 to 21
Sponsor: NCI, Other
Protocol IDs: CDR0000355177, PBTC-014, NCT00079339
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067632, NYU-9861, JRF-R115777-USA-8B, NCI-G00-1714, NCT00005041
14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02335, FCCC-00005, NCI-45, CDR0000067859, 45, NCT00005843
15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-99031, FCC-RRC-56-99, NCI-20, NCT00005848, 20
16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067888, NABTC-9901, NCT00005859
17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067978, U01CA069912, P30CA015083, 982401, MAYO-982401, NCI-T99-0072, T99-0072, NCT00005989
18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MCC-12162, JRF-R115777-INT-10, MCC-IRB-5623, NCI-G00-1861, NCT00006376
19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-12516, NIH-2030, MCC-12137, MCC-IRB-5442, NCT00012350
20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MCC-12516, MCC-IRB-6028, NCI-2030, 2030, NCT00021203
21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Child
Sponsor: NCI
Protocol IDs: NCI-2012-01861, AAML0122, U10CA098543, CDR0000068788, COG-AAML0122, NCT00025038
22.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 3 to 25
Sponsor: NCI
Protocol IDs: 010222, 01-C-0222, NCI-01-C-0222, NCI-T99-0090, NCT00029354, T99-0090, NCT00021541
23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-02423, RTOG-PA-0020, U10CA021661, CDR0000068986, RTOG-DEV-1003, NCT00026104
24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 65 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02980, UMGCC 0116, U01CA069854, U01CA070095, JHOC-J0255, MSGCC-U5400, MSGCC-0116, NCI-1754, 1754, NCT00027872
25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03158, J0252, U01CA070095, U01CA069854, JHOC-J0252, MSGCC-0150, NCI-5689, 5689, NCT00045396
1    
New Search